Navigation Links
BIO-key® Reports Strong 2010 Second Quarter and Six Month Financial Results
Date:7/28/2010

n class="xn-chron">June 30, 2010 and June 30, 2009, respectively. Accounting for income from derivative and warrant fair value adjustments and income from discontinued operations, BIO-key's net income for the six month period ended June 30, 2010 was $1,235,324 compared to net income of $361,819 for the same period in  2009. The 2009 first half income included approximately $2.0 million related to discontinued operations.

Liquidity and Capital Resources

Consolidated cash, cash equivalents and accounts receivables totaled over $2.4 million on June 30, 2010, compared to approximately $1.7 million as of December 31, 2009. 

Highlights for the second quarter included the following:

  • Contract award in excess of $560,000 from one of the nation's foremost organizations specializing in transfusion medicine and related services, for the deployment of our WEB-key software for donor identification.
  • Contract from an existing partner to deploy our technology for a new foreign customer.
  • Purchase orders totaling over $175,000 for a new deployment of our biometric software at Genesis HealthCare Systems in Ohio.
  • The first deployment with our newest partner, Epic. Their solution now includes our biometric software. Epic is a supplier of integrated software for mid-size to large medical groups and integrated healthcare organizations.
  • Our partner Sentillion (a Microsoft® Company) has completed the first
    '/>"/>

SOURCE BIO-key International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology news :

1. BIO-key® to Unveil Enterprise Ready Biometric Identity Platform for Smartphones at the Burton Group Catalyst Conference
2. International Drug & Explosives Detection Company IDenta Corp Reports on BTK- Bullet Hole Testing Kit
3. Cell Transplantation reports consistent and successful islet isolations offer diabetes hope
4. New climate change reports underscore need for action
5. BIO-key(R) Reports First Quarter 2010 Financial Results
6. Survey reports latest honey bee losses
7. Grupo Radio Centro Reports First Quarter 2010 Results
8. Primary Energy Reports Improved First Quarter Results
9. GEN reports on the promise of DNA vaccines
10. Peregrine reports new study from Duke shows anti-HIV potential of targeting PS on cells
11. NIH stem cell guidelines should be modified, UCSF team reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014 Research and Markets ... of the "The Global Watermarking and ... http://photos.prnewswire.com/prnh/20130307/600769 ... of the global digital media watermarking and ... monitor piracy by securely and invisibly embedding ...
(Date:12/19/2014)... 18, 2014  23andMe, Inc., the leading personal genetics ... pinpoints fine-scale differences in genetic ancestry of individuals from ... Since immigrants first arrived more than four hundred ... has served as a meeting place for peoples from ... the ongoing mixing of peoples with African, European, and ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Clinical Practices (GCP) audit to confirm its adherence ... regulations. This accomplishment enables HITLAB to conduct regulated ... the highest principles for patient safety and research ... global healthcare access, quality, and delivery with innovative ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... 14, 2010)--The New York Stem Cell Foundation (NYSCF) has ... Foundation, established by Julian and Josie Robertson. The ... provide funding for NYSCF-Robertson Investigators in NYSCF,s new Early ... NYSCF-Robertson Stem Cell Prize. This award program, ...
... are legendary for their lethal bites, but not all. Some ... explains that some cobras defend themselves by spraying debilitating venom ... work with spitting cobras in South Africa, Young took the ... eyes. Protected by a sheet of Perspex, Young caught the ...
... VA (May 13, 2010) Novel vaccines for diseases ... worth of biotechnology research at the American Association of ... academia, industry, and government will gather at the Hilton ... 20 to share research and advances in biotherapeutics. ...
Cached Biology News:Spitting cobras track first, predict later 2Cutting-edge vaccine research to be showcased at AAPS National Biotechnology Conference 2
(Date:12/19/2014)... Charm Sciences is pleased to announce that ... Aflatoxin M1 in raw commingled milk is the first ... The peer reviewed report of the validation by Technology ... and Fisheries Research (ILVO-T&V) has been published by the ... most toxic aflatoxin and a known carcinogen, can be ...
(Date:12/19/2014)... , Dec. 19, 2014 Bina Technologies, Inc. ... announced today that they have been acquired by Roche ... is a privately held company that provides a big ... generation sequencing (NGS) data for the academic and translational ... Sequencing Unit, and will continue to focus on development ...
(Date:12/19/2014)... December 18, 2014 Today, ... its pilot production facility and future company headquarters ... produce innovative new materials that safely and effectively ... only because of its historic, strong support for ... to attract leading edge, technology-based companies such as ...
(Date:12/19/2014)... iLab Solutions, the global leader in ... Bryant as the new Director of Institutional Implementations and ... These two new leadership positions were created to support ... that iLab continues to meet the needs of its ... iLab has been deployed at over 450 core facilities ...
Breaking Biology Technology:Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2
... President, Operations and Chief Financial Officer ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... Calif., Nov. 5, 2010 Clarient, Inc. (Nasdaq: ... unanimously agreed to recommend that Clarient stockholders tender their shares ... the previously announced price of $5.00 per share of Clarient,s ... Convertible Preferred Stock. The transaction is expected to ...
Cached Biology Technology:OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 2OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 3OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 4OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 5OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 6OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 7OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 8OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer 9Study Shows Cardiovascular Deaths in Europe Could Be Prevented 2Study Shows Cardiovascular Deaths in Europe Could Be Prevented 3Study Shows Cardiovascular Deaths in Europe Could Be Prevented 4Study Shows Cardiovascular Deaths in Europe Could Be Prevented 5Study Shows Cardiovascular Deaths in Europe Could Be Prevented 6Study Shows Cardiovascular Deaths in Europe Could Be Prevented 7Study Shows Cardiovascular Deaths in Europe Could Be Prevented 8Study Shows Cardiovascular Deaths in Europe Could Be Prevented 9Study Shows Cardiovascular Deaths in Europe Could Be Prevented 10Clarient's Board of Directors Recommends Stockholders Accept General Electric's Cash Tender Offer 2Clarient's Board of Directors Recommends Stockholders Accept General Electric's Cash Tender Offer 3Clarient's Board of Directors Recommends Stockholders Accept General Electric's Cash Tender Offer 4
Any form, any size, any number of mutageneses. ExonBio provides the best service with double sequecing to make sure the success of the mutagenesis....
Loading Buffer...
Request Info...
Request Info...
Biology Products: